OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Advancements in fourth-generation EGFR TKIs in EGFR-mutant NSCLC: Bridging biological insights and therapeutic development
Carla Corvaja, Antonio Passaro, Ilaria Attili, et al.
Cancer Treatment Reviews (2024) Vol. 130, pp. 102824-102824
Closed Access | Times Cited: 6
Carla Corvaja, Antonio Passaro, Ilaria Attili, et al.
Cancer Treatment Reviews (2024) Vol. 130, pp. 102824-102824
Closed Access | Times Cited: 6
Showing 6 citing articles:
Diverse clinical outcomes for the EGFR‑mutated and ALK‑rearranged advanced non‑squamous non‑small cell lung cancer
Chun-Wei Lin, Kuo‐Yang Huang, Ching‐Hsiung Lin, et al.
Oncology Letters (2025) Vol. 29, Iss. 3
Open Access | Times Cited: 1
Chun-Wei Lin, Kuo‐Yang Huang, Ching‐Hsiung Lin, et al.
Oncology Letters (2025) Vol. 29, Iss. 3
Open Access | Times Cited: 1
Real-world prognostic factors for first-line EGFR-TKI efficacy in advanced NSCLC patients harboring EGFR 21L858R mutation
Yan’e Liu, Lu Chen, Xin Zhu, et al.
Global Medical Genetics (2025), pp. 100051-100051
Open Access
Yan’e Liu, Lu Chen, Xin Zhu, et al.
Global Medical Genetics (2025), pp. 100051-100051
Open Access
Drug Resistance in Late-Stage Epidermal Growth Factor Receptor (EGFR)-Mutant Non-Small Cell Lung Cancer Patients After First-Line Treatment with Tyrosine Kinase Inhibitors
Ching‐Yi Lee, Shih‐Wei Lee, Yi‐Chiung Hsu
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 2042-2042
Open Access
Ching‐Yi Lee, Shih‐Wei Lee, Yi‐Chiung Hsu
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 2042-2042
Open Access
Next-Generation Sequencing in Oncology—A Guiding Compass for Targeted Therapy and Emerging Applications
Laurenţia Galeş, Mihai-Andrei Păun, Ioana Butnariu, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 3123-3123
Open Access
Laurenţia Galeş, Mihai-Andrei Păun, Ioana Butnariu, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 3123-3123
Open Access
From Challenges to Solutions: A Review of Fourth-Generation EGFR Tyrosine Kinase Inhibitors to Overcome the C797S Triple Mutation in Non-Small Cell Lung Cancer
Iqrar Ahmad, Harun Patel
European Journal of Medicinal Chemistry (2024) Vol. 284, pp. 117178-117178
Closed Access | Times Cited: 1
Iqrar Ahmad, Harun Patel
European Journal of Medicinal Chemistry (2024) Vol. 284, pp. 117178-117178
Closed Access | Times Cited: 1
Phenotypic plasticity in a novel set of EGFR tyrosine kinase inhibitor-adapted non-small cell lung cancer cell lines
Tharsagini Nanthaprakash, Campbell W. Gourlay, Ina Oehme, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Tharsagini Nanthaprakash, Campbell W. Gourlay, Ina Oehme, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Orthoallosteric EGFR‐TKIs: A New Paradigm in NSCLC Treatment Strategy Targeting the C797S Mutation
Iqrar Ahmad, Harun Patel
Drug Development Research (2024) Vol. 86, Iss. 1
Closed Access
Iqrar Ahmad, Harun Patel
Drug Development Research (2024) Vol. 86, Iss. 1
Closed Access
